Evidence map›Paper›PMID 35018331›Full record

ArticleAccess microbiology2021

Prevalence and antibiotic resistance of

Busayo I Ajuwon, Sola K Babatunde, Olatunji M Kolawole, Adeyinka E Ajiboye, Abosede H Lawal

Open access · goldAbstract read
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. ESBL- and pAmpC-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Busayo I AjuwonNational Centre for Epidemiology and Population Health, Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT 2601, Australia.ORCID https://orcid.org/0000-0003-4034-3617
Sola K BabatundeDepartment of Natural and Environmental Sciences, Faculty of Science, Crown-Hill University, Ilorin, Kwara State, Nigeria.
Olatunji M KolawoleDepartment of Microbiology, Faculty of Life Sciences, University of Ilorin, Ilorin, Nigeria.
Adeyinka E AjiboyeDepartment of Biosciences and Biotechnology, Faculty of Pure and Applied Sciences, Kwara State University, Malete, Nigeria.
Abosede H LawalCentre for Occupational and Environmental Public Health, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff, UK.
Australian National University · AUCardiff Metropolitan University · GBKwara State University · NGUniversity of Ilorin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastroenteritis due to foodborne disease is a leading cause of death in developing countries. In Nigeria, there is an increasing demand for beef. Yet, there is no surveillance for

methodsA total of 415 samples, including 180 cow carcass swabs, 180 caecal content samples, 16 water samples, 25 hand swabs and 14 knife swabs were collected at a large abattoir in the Moro region of Kwara State, Nigeria. The samples were enriched in modified tryptone broth containing novobiocine, and plated onto Sorbitol-MacConkey agar (Oxoid SR0172E) supplemented with 0.05 mg l

resultsOverall, 16 (3.9 %) samples were contaminated with

conclusionThis study provides evidence to suggest that

Indexed as

antibiotic susceptibilitybeefE. coli O157:H7gastroenteritisprevalence

Identifiers

PMID35018331
PMCPMC8742587
OpenAlexW3214130354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.